Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Invitae Corp
(NY:
NVTA
)
50.65
USD
-1.58 (-3.02%)
Streaming Delayed Price
Updated: 12:58 PM EST, Jan 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Invitae Corp
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Bear Of The Day: Illumina (ILMN)
January 25, 2021
After a projected 33% drop in EPS for 2020 from $6.57 to $4.39, profits for ILMN are expected to bounce back to $5.82 in 2021.
Tags
Healthcare
Stocks / Equities
From
Blogs - TalkMarkets
Schaeffer's Investment Research: Top 2 Contrarian Stock Picks For 2021
January 22, 2021
Typically speaking, contrarian involves going against the grain, either by buying stocks most other investors are selling, or vice ...
Tags
Contrarian stocks
FLGT
Benzinga
From
Benzinga
Invitae Announces Pricing of Public Offering of Common Stock
January 21, 2021
Invitae Corporation (NYSE: NVTA) today announced the pricing of an underwritten public offering of 7,766,990 shares of its common stock at a price to the public of $51.50 per share. All of the shares...
From
PR Newswire
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
January 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
CELC
AVIR
JAZZ
From
Benzinga
10 Stocks Moving In Thursday's After-Hours Session
January 20, 2021
Gainers Kinder Morgan (NYSE: KMI) shares are trading higher after the company announced better-than-expected Q4 EPS and sales ...
Tags
NVTA
News
Benzinga
From
Benzinga
Invitae Announces Proposed Public Offering of Common Stock
January 20, 2021
Invitae Corporation (NYSE: NVTA) today announced that it has commenced an underwritten public offering of $400.0 million of shares of its common stock, before deducting underwriting discounts and...
From
PR Newswire
Looking For The Top Biotech Stocks To Watch Right Now? 1 Up 200%+ In One Day
January 20, 2021
Tags
Market News
From
Stockmarket.com
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
January 14, 2021
Those are some solid endorsements.
Tags
JNJ
Market News
BMY
From
Motley Fool
Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)
January 14, 2021
-- Project aims to standardize MRD data generation, assessment and accelerate AML clinical trial programs bringing novel therapies to patients in need faster --
From
PR Newswire
Why Invitae Stock Flew Higher Today
January 13, 2021
Investors appear to like the company's new collaboration with PacBio.
Tags
NVTA
PACB
Market News
From
Motley Fool
Why Is It Moving? Looking At Invitae's Price Action Today
January 13, 2021
The Price And Volume Action In Invitae's Stock Today Invitae's (NYSE:NVTA) stock has been rising Wednesday, up 9.03% to a ...
Tags
Benzinga
Trading Ideas
NVTA
From
Benzinga
Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform
January 13, 2021
New platform expected to make whole genome sequencing significantly more affordable and accessible for use in mainstream medical care
From
GlobeNewswire News Releases
These 3 Big 2020 Stock Market Winners Took Big Hits Monday
January 11, 2021
Should investors be worried?
Tags
^IXIC
Market News
^GSPC
From
Motley Fool
Notable Monday Option Activity: NVTA, ATSG, KTB
January 11, 2021
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Invitae Corp (NVTA), where a total of 27,303 contracts have traded so far, representing...
Tags
Stocks
From
Market News Video
12 Health Care Stocks Moving In Monday's Intraday Session
January 11, 2021
Gainers Geovax Labs (NASDAQ:GOVX) shares rose 64.24% to $5.42 during Monday's regular session. Trading volume for ...
Tags
NVTA
Top Gainers
Benzinga
From
Benzinga
Stocks Extend Losses Amid Calls for Trump's Removal
January 11, 2021
Stocks are lower this afternoon, extending this morning's retreat from record levels.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Looking Into Invitae's Return On Capital Employed
January 11, 2021
During Q3, Invitae (NYSE:NVTA) brought in sales totaling $68.73 million. However, earnings decreased 43.12%, resulting in a loss of ...
Tags
Market News
BZI/ROCE
Benzinga
From
Benzinga
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
January 11, 2021
-- Presenting at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021 at 10:50 a.m. Eastern/7:50 a.m. Pacific --
From
PR Newswire
Best ETFs And Mutual Funds Ended 2020 With A Bang
January 08, 2021
The best mutual funds for the month included small-cap growth and small-cap value funds, surging 8.79% and 7.35%, respectively.
From
Investor's Business Daily
Invitae Larger Than S&P 500 Component Invesco
January 05, 2021
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Invitae Corp (NVTA) was identified as having a larger market cap than the smaller end of the S&P 500, for...
Tags
Stocks
From
Market News Video
Move Over, Warren Buffett: This Is the Star Investor You Should Be Following
December 30, 2020
Berkshire's best days seem to be behind it, but this investing wiz could be the next Buffett.
Tags
ARKF
Market News
TSLA
From
Motley Fool
Invitae to Present at the 39th Annual J.P. Morgan Healthcare Conference
December 29, 2020
Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the 39th Annual J.P. Morgan...
From
PR Newswire
Are Genomic Stocks Are The Next FANG Stocks?
December 24, 2020
Some of the best performing ETFs in 2020 have been the Ark Funds, actively managed ETFs led by Cathie Wood. A long-time Tesla Inc ...
Tags
CRSP
TSLA
Market News
From
Benzinga
10 Health Care Stocks With Unusual Options Alerts In Today's Session
December 17, 2020
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the ...
Tags
General
Options
INO
From
Benzinga
Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses Faster
December 17, 2020
-- Artificial intelligence-powered technology helps bring the benefits of comprehensive clinical sequencing to patient care while maintaining exceptional accuracy and reproducibility --
From
PR Newswire
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
December 15, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Penny Stocks
OTIC
PRAX
From
Benzinga
Stocks That Hit 52-Week Highs On Monday
December 14, 2020
Monday's morning session saw 240 companies set new 52-week highs. Key Facts: The largest company by market cap to ...
Tags
ACHC
FARO
EXPI
From
Benzinga
Notable Friday Option Activity: VIAC, NVTA, NVAX
December 11, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in ViacomCBS Inc (VIAC), where a total volume of 72,999 contracts has been traded thus...
Tags
Stocks
From
Market News Video
Stocks That Hit 52-Week Highs On Friday
December 11, 2020
This morning 167 companies reached new 52-week highs. Noteables: Walt Disney (NYSE: DIS) was the largest firm on a ...
Tags
Markets
Intraday Update
BILI
From
Benzinga
Five investing rules from a money manager who crushes the stock market — and his take on the best companies to own now
December 11, 2020
Alexander Ely of the Delaware Smid Cap Growth Fund invests in disruptive companies including Square, Boston Beer and Yeti.
Tags
SQ
SAM
TDOC
From
MarketWatch
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.